3-year rate (%) | 5-year rate (%) | p value | |
---|---|---|---|
Overall Survival | |||
Radiation therapy | |||
Pre-operative RT | 80 | 54 | 0.85 |
Post-operative RT | 62 | 48 | |
Surgical Margins | |||
Negative (R0) | 92 | 78 | 0.09 |
Positive (R1) | 52 | 35 | |
Chemotherapy | |||
Yes | 67 | 53 | 0.74 |
No | 69 | 48 | |
Histology | |||
LMS | 77 | 58 | 0.48 |
Liposarcoma | 67 | 50 | |
Other | 60 | 45 | |
Grade | |||
Low | 86 | 57 | 0.58 |
High | 65 | 50 | |
Local Control | |||
Radiation therapy | |||
Pre-operative RT | 100 | 100 | 0.10 |
Post-operative RT | 77 | 69 | |
Surgical Margins | |||
Negative (R0) | 100 | 100 | 0.02 |
Positive (R1) | 79 | 60 | |
Chemotherapy | |||
Yes | 65 | 65 | 0.16 |
No | 94 | 85 | |
Histology | |||
LMS | 100 | 100 | 0.06 |
Liposarcoma | 100 | 75 | |
Other | 58 | 58 | |
Grade | |||
Low | 100 | 100 | 0.09 |
High | 77 | 68 | |
Distant Metastasis | |||
Radiation therapy | |||
Pre-operative RT | 32 | 55 | 0.91 |
Post-operative RT | 38 | 45 | |
Surgical Margins | |||
Negative (R0) | 25 | 34 | 0.16 |
Positive (R1) | 27 | 45 | |
Chemotherapy | |||
Yes | 55 | 55 | 0.69 |
No | 26 | 44 | |
Histology | |||
LMS | 50 | 50 | 0.53 |
Liposarcoma | 11 | 33 | |
Other | 40 | 55 | |
Grade | |||
Low | 25 | 40 | 0.54 |
High | 40 | 49 |